Pilot Program Demonstrates Supply Chain Transparency Can Mitigate Oncology Drug Shortages

A groundbreaking Drug Resiliency & Transparency Pilot, led by the End Drug Shortages Alliance (EDSA), has shown that hospitals, distributors, and other stakeholders can effectively share sensitive inventory data. This initiative, which emerged from a White House roundtable on pediatric oncology drug shortages, proved that such transparency creates valuable planning insights, even in the absence of an active shortage, and can help protect access to critical medications.